These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3509775)

  • 21. Cerebral involvement in systemic lupus erythematosus (SLE): comparison of positron emission tomography (PET) with other imaging methods.
    Meyer GJ; Schober O; Stoppe G; Wildhagen K; Seidel JW; Hundeshagen H
    Psychiatry Res; 1989 Sep; 29(3):367-8. PubMed ID: 2608795
    [No Abstract]   [Full Text] [Related]  

  • 22. [Positron emission tomography and evoked potentials in the early detection of hereditary ataxias].
    Nowak A; Holthoff V; Haupt WF
    Nervenarzt; 1989 May; 60(5):284-7. PubMed ID: 2786999
    [No Abstract]   [Full Text] [Related]  

  • 23. Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder.
    Saito T; Tamura M; Chiba Y; Katsuse O; Suda A; Kamada A; Ikura T; Abe K; Ogawa M; Minegishi K; Yoshimi R; Kirino Y; Ihata A; Hirayasu Y
    J Neurol Sci; 2017 Aug; 379():127-130. PubMed ID: 28716225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomography.
    de Jong BM; Pruim J; Sinnige LG; Beintema KD; Spronk PE; Bootsma H; Kallenberg CG; van Zomeren AH; Haaxma-Reiche H
    Eur Neurol; 1999; 41(4):187-93. PubMed ID: 10343148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration.
    De Volder AG; Francart J; Laterre C; Dooms G; Bol A; Michel C; Goffinet AM
    Ann Neurol; 1989 Aug; 26(2):239-47. PubMed ID: 2789014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
    Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
    Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron emission tomography in cases of chorea with different underlying diseases.
    Hosokawa S; Ichiya Y; Kuwabara Y; Ayabe Z; Mitsuo K; Goto I; Kato M
    J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1284-7. PubMed ID: 2960785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography in cases of chorea with different underlying disease.
    Lang AE; Garnett ES
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):1010-1. PubMed ID: 3264566
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduced regional cerebral metabolic rate for glucose at the terminal stage in a case of late infantile neuronal ceroid lipofuscinosis.
    Fueki N; Iinuma K; Kojima A; Yanai K; Haginoya K; Tada K; Ido T; Ito M
    J Child Neurol; 1990 Apr; 5(2):98-100. PubMed ID: 2345285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis.
    Oechsner M; Buchert R; Beyer W; Danek A
    J Neurol Neurosurg Psychiatry; 2001 Apr; 70(4):517-20. PubMed ID: 11254778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign hereditary chorea: clinical and neuroimaging features in an Italian family.
    Salvatore E; Di Maio L; Filla A; Ferrara AM; Rinaldi C; Saccà F; Peluso S; Macchia PE; Pappatà S; De Michele G
    Mov Disord; 2010 Jul; 25(10):1491-6. PubMed ID: 20544814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternating hemichorea in primary antiphospholipid syndrome: evidence for contralateral striatal hypermetabolism.
    Furie R; Ishikawa T; Dhawan V; Eidelberg D
    Neurology; 1994 Nov; 44(11):2197-9. PubMed ID: 7969986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe Contralateral Striatal Hypometabolism in a Case of Diabetic Nonketotic Hyperglycemic Hemichorea on 18F-FDG PET/CT Brain.
    Kumar Vadi S; Mehta S; Kumar R; Tandyala N; Singh H; Mittal BR
    Clin Nucl Med; 2020 Feb; 45(2):e117-e119. PubMed ID: 31714279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography in the early diagnosis of Huntington's disease.
    Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T
    Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cerebral positron emission tomographic study in systemic lupus erythematosus].
    Csépány T; Gulyás B; Trón L; Szakáll S; Kiss E; Kollár J; Sikula J; Szegedi G; Csiba L
    Orv Hetil; 1997 Aug; 138(31):1947-52. PubMed ID: 9280887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chorea: general aspect and classification].
    Nagura H
    Nihon Rinsho; 1993 Nov; 51(11):2829-34. PubMed ID: 8277557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain glucose utilization in childhood Huntington's disease studied with positron emission tomography (PET).
    De Volder A; Bol A; Michel C; Cogneau M; Evrard P; Lyon G; Goffinet AM
    Brain Dev; 1988; 10(1):47-50. PubMed ID: 2967038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain glucose metabolism in thalamic syndrome.
    Laterre EC; De Volder AG; Goffinet AM
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):427-8. PubMed ID: 3258903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI].
    Stoppe G; Wildhagen K; Meyer GJ; Schober O
    Nuklearmedizin; 1989 Oct; 28(5):187-92. PubMed ID: 2813082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in striatal metabolism in diabetic haemichorea-haemiballism.
    Hashimoto T; Oguchi K; Takeuchi R
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23008367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.